Comparison of prostate-specific promoters and the use of PSP-driven virotherapy for prostate cancer.
about
On the potential of oncolytic virotherapy for the treatment of canine cancers.Targeting strategies of adenovirus‑mediated gene therapy and virotherapy for prostate cancer (Review).Advances in the mechanisms of action of cancer-targeting oncolytic viruses.Improving adenoviral vectors and strategies for prostate cancer gene therapySafety of an Oncolytic Myxoma Virus in Dogs with Soft Tissue Sarcoma
P2860
Comparison of prostate-specific promoters and the use of PSP-driven virotherapy for prostate cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Comparison of prostate-specifi ...... rotherapy for prostate cancer.
@en
Comparison of prostate-specifi ...... rotherapy for prostate cancer.
@nl
type
label
Comparison of prostate-specifi ...... rotherapy for prostate cancer.
@en
Comparison of prostate-specifi ...... rotherapy for prostate cancer.
@nl
prefLabel
Comparison of prostate-specifi ...... rotherapy for prostate cancer.
@en
Comparison of prostate-specifi ...... rotherapy for prostate cancer.
@nl
P2093
P2860
P356
P1476
Comparison of prostate-specifi ...... rotherapy for prostate cancer.
@en
P2093
P2860
P304
P356
10.1155/2013/624632
P407
P577
2013-01-31T00:00:00Z